<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Borgheai, Seyyed Bahram</style></author><author><style face="normal" font="default" size="100%">McLinden, John</style></author><author><style face="normal" font="default" size="100%">Zisk, Alyssa Hillary</style></author><author><style face="normal" font="default" size="100%">Hosni, Sarah Ismail</style></author><author><style face="normal" font="default" size="100%">Deligani, Roohollah Jafari</style></author><author><style face="normal" font="default" size="100%">Abtahi, Mohammadreza</style></author><author><style face="normal" font="default" size="100%">Mankodiya, Kunal</style></author><author><style face="normal" font="default" size="100%">Shahriari, Yalda</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Enhancing Communication for People in Late-Stage ALS Using an fNIRS-Based BCI System.</style></title><secondary-title><style face="normal" font="default" size="100%">IEEE Trans Neural Syst Rehabil Eng</style></secondary-title><alt-title><style face="normal" font="default" size="100%">IEEE Trans Neural Syst Rehabil Eng</style></alt-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Amyotrophic Lateral Sclerosis</style></keyword><keyword><style  face="normal" font="default" size="100%">brain-computer interfaces</style></keyword><keyword><style  face="normal" font="default" size="100%">Communication</style></keyword><keyword><style  face="normal" font="default" size="100%">Electroencephalography</style></keyword><keyword><style  face="normal" font="default" size="100%">Humans</style></keyword><keyword><style  face="normal" font="default" size="100%">Spectroscopy, Near-Infrared</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style  face="normal" font="default" size="100%">05/2020</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">28</style></volume><pages><style face="normal" font="default" size="100%">1198-1207</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;&lt;b&gt;OBJECTIVE: &lt;/b&gt;Brain-computer interface (BCI) based communication remains a challenge for people with later-stage amyotrophic lateral sclerosis (ALS) who lose all voluntary muscle control. Although recent studies have demonstrated the feasibility of functional near-infrared spectroscopy (fNIRS) to successfully control BCIs primarily for healthy cohorts, these systems are yet inefficient for people with severe motor disabilities like ALS. In this study, we developed a new fNIRS-based BCI system in concert with a single-trial Visuo-Mental (VM) paradigm to investigate the feasibility of enhanced communication for ALS patients, particularly those in the later stages of the disease.&lt;/p&gt;&lt;p&gt;&lt;b&gt;METHODS: &lt;/b&gt;In the first part of the study, we recorded data from six ALS patients using our proposed protocol (fNIRS-VM) and compared the results with the conventional electroencephalography (EEG)-based multi-trial P3Speller (P3S). In the second part, we recorded longitudinal data from one patient in the late locked-in state (LIS) who had fully lost eye-gaze control. Using statistical parametric mapping (SPM) and correlation analysis, the optimal channels and hemodynamic features were selected and used in linear discriminant analysis (LDA).&lt;/p&gt;&lt;p&gt;&lt;b&gt;RESULTS: &lt;/b&gt;Over all the subjects, we obtained an average accuracy of 81.3%±5.7% within comparatively short times (&lt; 4 sec) in the fNIRS-VM protocol relative to an average accuracy of 74.0%±8.9% in the P3S, though not competitive in patients with no substantial visual problems. Our longitudinal analysis showed substantially superior accuracy using the proposed fNIRS-VM protocol (73.2%±2.0%) over the P3S (61.8%±1.5%).&lt;/p&gt;&lt;p&gt;&lt;b&gt;SIGNIFICANCE: &lt;/b&gt;Our findings indicate the potential efficacy of our proposed system for communication and control for late-stage ALS patients.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Schachter, Steven C</style></author><author><style face="normal" font="default" size="100%">Guttag, John</style></author><author><style face="normal" font="default" size="100%">Schiff, Steven J</style></author><author><style face="normal" font="default" size="100%">Schomer, Donald L</style></author></authors><translated-authors><author><style face="normal" font="default" size="100%">Summit Contributors</style></author></translated-authors></contributors><titles><title><style face="normal" font="default" size="100%">Advances in the application of technology to epilepsy: the CIMIT/NIO Epilepsy Innovation Summit.</style></title><secondary-title><style face="normal" font="default" size="100%">Epilepsy Behav</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Epilepsy Behav</style></alt-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Adult</style></keyword><keyword><style  face="normal" font="default" size="100%">Anticonvulsants</style></keyword><keyword><style  face="normal" font="default" size="100%">Brain Mapping</style></keyword><keyword><style  face="normal" font="default" size="100%">Child</style></keyword><keyword><style  face="normal" font="default" size="100%">Drug Resistance</style></keyword><keyword><style  face="normal" font="default" size="100%">Electric Stimulation Therapy</style></keyword><keyword><style  face="normal" font="default" size="100%">Electroencephalography</style></keyword><keyword><style  face="normal" font="default" size="100%">Engineering</style></keyword><keyword><style  face="normal" font="default" size="100%">Epilepsy</style></keyword><keyword><style  face="normal" font="default" size="100%">Humans</style></keyword><keyword><style  face="normal" font="default" size="100%">Magnetic Resonance Imaging</style></keyword><keyword><style  face="normal" font="default" size="100%">Medical Laboratory Science</style></keyword><keyword><style  face="normal" font="default" size="100%">Microelectrodes</style></keyword><keyword><style  face="normal" font="default" size="100%">Nanoparticles</style></keyword><keyword><style  face="normal" font="default" size="100%">Neurons</style></keyword><keyword><style  face="normal" font="default" size="100%">Neurosurgery</style></keyword><keyword><style  face="normal" font="default" size="100%">Neurotoxins</style></keyword><keyword><style  face="normal" font="default" size="100%">Predictive Value of Tests</style></keyword><keyword><style  face="normal" font="default" size="100%">Seizures</style></keyword><keyword><style  face="normal" font="default" size="100%">Spectroscopy, Near-Infrared</style></keyword><keyword><style  face="normal" font="default" size="100%">Tomography, Emission-Computed, Single-Photon</style></keyword><keyword><style  face="normal" font="default" size="100%">Tomography, Optical</style></keyword><keyword><style  face="normal" font="default" size="100%">Transcranial Magnetic Stimulation</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style  face="normal" font="default" size="100%">09/2009</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.ncbi.nlm.nih.gov/pubmed/19780225</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">3-46</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;&lt;span style=&quot;font-family: arial, helvetica, clean, sans-serif; font-size: 13px; line-height: 17px;&quot;&gt;In 2008, a group of clinicians, scientists, engineers, and industry representatives met to discuss advances in the application of engineering technologies to the diagnosis and treatment of patients with epilepsy. The presentations also provided a guide for further technological development, specifically in the evaluation of patients for epilepsy surgery, seizure onset detection and seizure prediction, intracranial treatment systems, and extracranial treatment systems. This article summarizes the discussions and demonstrates that cross-disciplinary interactions can catalyze collaborations between physicians and engineers to address and solve many of the pressing unmet needs in epilepsy.&lt;/span&gt;&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue></record></records></xml>